Fundraising Fox

xMD Diagnostics

Annapolis, US · Maryland corporation · 2 known investors

xMD Diagnostics develops laboratory instruments and consumables for molecular diagnostics, aimed at enriching samples for downstream molecular testing. It serves research, biopharmaceutical, and clinical (CLIA) laboratories to help pathologists, oncologists, and other physicians diagnose, monitor, and treat cancer and other genetic diseases.

Founders & leadership

BSBenjamin Shapiro
Benjamin ShapiroCo-Founder, Technical Advisor
AF
Al FleuryExecutive
TPTing Pau Oei
Ting Pau OeiinCEO and Co-Chairman
ME
Michael Emmert-BuckNamed on SEC filing
NMNicole Massoll, M.D.
Nicole Massoll, M.D.Medical Director, Pathologist

Board

SRStephen Ritterbush
Stephen RitterbushCFO and Co-Chairman

Investors · 2

Reported raises · per SEC filings

Form D private placements

$675K disclosed across 2 rounds · 2017–2018

$500KraisedOct 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen R. RitterbushExecutive Officer, Director
  • Ting Pau OeiExecutive Officer, Director
  • Benjamin ShapiroExecutive Officer, Director
Offering amount
$3.5M
Amount sold
$500K
First sale
Oct 2018
Incorporated
Corporation, Maryland
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$175KraisedMar 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Al FleuryExecutive Officer
  • Michael Emmert-BuckExecutive Officer
  • Ting Pau OeiExecutive Officer, Director
  • Benjamin ShapiroExecutive Officer, Director
  • Stephen RitterbushExecutive Officer, Director
Offering amount
$350K
Amount sold
$175K
Proceeds to insiders
$35K
First sale
Jan 2017
Incorporated
Limited Liability Company, Maryland
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with xMD Diagnostics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase I2021$256K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does xMD Diagnostics do?
xMD Diagnostics develops laboratory instruments and consumables for molecular diagnostics, aimed at enriching samples for downstream molecular testing. It serves research, biopharmaceutical, and clinical (CLIA) laboratories to help pathologists, oncologists, and other physicians diagnose, monitor, and treat cancer and other genetic diseases.
Who founded xMD Diagnostics?
xMD Diagnostics was founded by Benjamin Shapiro.
Who are xMD Diagnostics's investors?
xMD Diagnostics's investors include Maryland TEDCO, TEDCO.
How much funding has xMD Diagnostics raised?
xMD Diagnostics has disclosed $675K raised across 2 rounds.
Where is xMD Diagnostics headquartered?
xMD Diagnostics is headquartered in Annapolis, US.